Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults

NCT01993706 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

NIH

Sponsor class

Conditions

HIV Infection
Monoclonal Antibody, Human
HIV Antibodies
VRC01 Monoclonal Antibody
Neutralizing Antibody

Interventions

DRUG: VRC-HIVMAB060-00-AB

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)